|
"lin yi ling"的相關文件
顯示項目 6-15 / 125 (共13頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 南華大學 |
2022-06-01 |
唯識視域下的莊子齊物思想—《齊物論釋》之「喪我」功夫論述
|
林憶玲; Lin, Yi-Ling |
| 臺大學術典藏 |
2022-05-25T07:09:06Z |
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
|
SZU-MIN HSIEH; Liu, Ming-Che; Chen, Yen-Hsu; Lee, Wen-Sen; Hwang, Shinn-Jang; Cheng, Shu-Hsing; Ko, Wen-Chien; Hwang, Kao-Pin; Wang, Ning-Chi; Lee, Yu-Lin; Lin, Yi-Ling; Shih, Shin-Ru; Huang, Chung-Guei; Liao, Chun-Che; Liang, Jian-Jong; Chang, Chih-Shin; Chen, Charles; Lien, Chia En; Tai, I-Chen; Lin, Tzou-Yien |
| 臺大學術典藏 |
2022-05-14T23:36:18Z |
Functional chicken-liver hydrolysates ameliorate insulin resistance and cognitive decline in streptozotocin-induced diabetic mice
|
Yeh, Wei Yu; Lin, Yi Ling; WEN-YUAN YANG; CHUNG-HSI CHOU; Wu, Yi Hsieng Samuel; YI-CHEN CHEN |
| 臺大學術典藏 |
2022-05-12T05:28:28Z |
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
|
Hsieh, Wan-Chen; Lai, En-Yu; Liu, Yu-Ting; Wang, Yi-Fu; Tzeng, Yi-Shiuan; Cui, Lu; Lai, Yun-Ju; Huang, Hsiang-Chi; Huang, Jia-Hsin; Ni, Hung-Chih; Tsai, Dong-Yan; Liang, Jian-Jong; Liao, Chun-Che; Lu, Ya-Ting; Jiang, Laurence; Liu, Ming-Tsan; Wang, Jann-Tay; SUI-YUAN CHANG; Chen, Chung-Yu; Tsai, Hsing-Chen; Chang, Yao-Ming; Wernig, Gerlinde; Li, Chia-Wei; Lin, Kuo-I; Lin, Yi-Ling; Tsai, Huai-Kuang; Huang, Yen-Tsung; Chen, Shih-Yu |
| 臺大學術典藏 |
2022-03-08T08:51:01Z |
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
|
Hsieh, Wan-Chen; Lai, En-Yu; Liu, Yu-Ting; Wang, Yi-Fu; Tzeng, Yi-Shiuan; Cui, Lu; Lai, Yun-Ju; Huang, Hsiang-Chi; Huang, Jia-Hsin; Ni, Hung-Chih; Tsai, Dong-Yan; Liang, Jian-Jong; Liao, Chun-Che; Lu, Ya-Ting; Jiang, Laurence; Liu, Ming-Tsan; Wang, Jann-Tay; Chang, Sui-Yuan; Chen, Chung-Yu; HSING-CHEN TSAI; Chang, Yao-Ming; Wernig, Gerlinde; Li, Chia-Wei; Lin, Kuo-I; Lin, Yi-Ling; Tsai, Huai-Kuang; Huang, Yen-Tsung; Chen, Shih-Yu |
| 臺大學術典藏 |
2021-12-14T23:12:05Z |
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
|
SZU-MIN HSIEH; Liu, Ming Che; Chen, Yen Hsu; Lee, Wen Sen; Hwang, Shinn Jang; Cheng, Shu Hsing; Ko, Wen Chien; Hwang, Kao Pin; Wang, Ning Chi; Lee, Yu Lin; Lin, Yi Ling; Shih, Shin Ru; Huang, Chung Guei; Liao, Chun Che; Liang, Jian Jong; Chang, Chih Shin; Chen, Charles; Lien, Chia En; Tai, I. Chen; Lin, Tzou Yien |
| 臺大學術典藏 |
2021-11-07T07:20:43Z |
Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
|
Hsu, Hsing-Yu; Yang, Cheng-Wei; Lee, Yue-Zhi; Lin, Yi-Ling; SUI-YUAN CHANG; Yang, Ruey-Bing; Liang, Jian-Jong; Chao, Tai-Ling; Liao, Chun-Che; Kao, Han-Chieh; Wu, Szu-Huei; Chang, Jang-Yang; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju |
| 臺大學術典藏 |
2021-09-14T23:18:49Z |
Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
|
Hsu, Hsing Yu; Yang, Cheng Wei; Lee, Yue Zhi; Lin, Yi Ling; SUI-YUAN CHANG; Yang, Ruey Bing; Liang, Jian Jong; Chao, Tai Ling; Liao, Chun Che; Kao, Han Chieh; Wu, Szu Huei; Chang, Jang Yang; Sytwu, Huey Kang; Chen, Chiung Tong; Lee, Shiow Ju |
| 臺大學術典藏 |
2021-08-15T00:08:48Z |
Pepsin-digested chicken-liver hydrolysate attenuates hepatosteatosis by relieving hepatic and peripheral insulin resistance in long-term high-fat dietary habit
|
Wu, Yi Hsieng Samuel; Lin, Yi Ling; WEN-YUAN YANG; SHENG-YAO WANG; YI-CHEN CHEN |
| 臺大學術典藏 |
2021-07-21T23:21:31Z |
Protective effects of crude chalaza hydrolysates against liver fibrogenesis via antioxidation, anti-inflammation/anti-fibrogenesis, and apoptosis promotion of damaged hepatocytes
|
Lin, Yi Ling; Lu, Ching Fu; Wu, Yi Hsieng Samuel; Yang, Kuo Tai; WEN-YUAN YANG; Chen, Jr Wei; Tseng, Jung Kai; YI-CHEN CHEN |
顯示項目 6-15 / 125 (共13頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
